Background Sanofi has decided to invest into new large state-of-the art facilities for the full portfolio for insulin Drug Substances to ensure future oriented, sustainable, reliable and leading-edge long-term supply for world-wide Diabetes patients. The new
Background Sanofi has decided to invest into new large state-of-the art facilities for the full portfolio for insulin Drug Substances to ensure future oriented, sustainable, reliable and leading-edge long-term supply for world-wide Diabetes patients. The new
Company Description As a global key player in yeasts and fermentation, Lesaffre designs, manufactures and markets innovative solutions for Baking, Food taste & pleasure, Health care and Biotechnology. Family group born in northern France in 1853, now a